Effects of a Mediterranean Eating Plan on the Need for Glucose-Lowering Medications in Participants With Type 2 Diabetes: A Subgroup Analysis of the PREDIMED Trial.
F Javier Basterra-GortariMiguel Ruiz-CanelaMaría Ángeles MartínezNancy BabioJosé V SorlíMontserrat FitoEmilio RosEnrique Gómez-GraciaMiquel FiolJosé LapetraRamón EstruchLuis Serra-MajemXavier PintoJosé I GonzálezMónica BulloOlga CastañerÁngel Alonso-GómezLuis ForgaFernando Arosnull nullPublished in: Diabetes care (2019)
Among participants with type 2 diabetes, a Med-EatPlan + EVOO may delay the introduction of new-onset glucose-lowering medications. The Med-EatPlan did not result in a significantly lower need for insulin.